FHI 360: Final Results Of FEM-PrEP HIV-Prevention Study Indicate Great Attention To Adherence Will Be Required In PrEP Programs
13:35 EDT 11 Jul 2012 | PR Newswire
This article has expired, however you can still
download the PDF.
Preview:
RESEARCH TRIANGLE PARK, N.C., July 11, 2012 /PRNewswire-USNewswire/ -- Results of the FHI 360 FEM-PrEP HIV-prevention trial reinforce the key role of adherence in HIV-prevention studies and the need to determine better approaches to support adherence in fu...
Other Sources for this Article
More From BioPortfolio on "FHI 360: Final Results Of FEM-PrEP HIV-Prevention Study Indicate Great Attention To Adherence Will Be Required In PrEP Programs"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
